Symetryx Corp - 14 Sep 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
10%+ Owner
Signature
Barry Shiff
Issuer symbol
NBSE
Transactions as of
14 Sep 2023
Transactions value $
-$375,620
Form type
4
Filing time
18 Sep 2023, 17:32:12 UTC
Previous filing
11 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$185,915 -129,108 -46% $1.44 153,337 14 Sep 2023 Direct
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$130,204 -103,337 -67% $1.26 50,000 15 Sep 2023 Direct
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$59,500 -50,000 -100% $1.19 0 18 Sep 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

As of September 18, 2023, Symetryx Corporation does not own any shares of Common Stock of NeuBase Therapeutics, Inc.